HDAC9 and neoplasm: Compared to controls, inoculation with the TSA-modulated TAMs resulted in a significant decrease in tumour burden in the recipient mice, suggesting that HDAC inhibition epigenetically rewires macrophages into an M1 state, decreasing phenotypic plasticity and thereby stabilising their anti-tumour activity.